The broader market would have to cooperate, and the AI narrative would have to return for, NVDA stock to break above $220 ...

Shares in Ubisoft jumped Monday, after the videogame company's new title “Assassin’s Creed Shadows” clocked up 2 million ...

Shares jumped after “Assassin’s Creed Shadows” garnered 2 million players less than a week since its release, surpassing the ...

Nvidia (NASDAQ:NVDA) isn’t the first name that comes to mind in healthcare, but its far-reaching influence makes it a strong ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

Viking Therapeutics ( VKTX -0.30%) is a promising growth stock with a strong GLP-1 drug candidate in VK2735, which may ...

FunCrazy, a Beijing-based brand focused on developing IPs and specialized in original 3D artwork, has partnered with the ...

The next cancer blockbuster drug? The person behind the news was Evercore ISI pundit Cory Kasimov, who on Wednesday launched ...

All in all, even if Alnylam doesn’t look like the cheapest biotech today, I think its proven R&D engine, strong pipeline, and near-term revenue growth opportunities do still make it a stock ...